cycloserine and Aura
cycloserine has been researched along with Aura in 6 studies
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Contreras, A; Forcada-Nadal, A; Rubio, V; Tremiño, L | 1 |
| Löscher, W; Rundfeldt, C; Wlaź, P | 1 |
| Czuczwar, SJ; Roliński, Z; Wlaź, P | 1 |
| Wlaź, P | 1 |
| Trendelenburg, F | 1 |
| Kutt, H; McDowell, FH; Winters, W | 1 |
Other Studies
6 other study(ies) available for cycloserine and Aura
| Article | Year |
|---|---|
Studies on cyanobacterial protein PipY shed light on structure, potential functions, and vitamin B
Topics: Amino Acid Motifs; Bacterial Proteins; Binding Sites; Cloning, Molecular; Crystallography, X-Ray; Cycloserine; Epilepsy; Escherichia coli; Gene Expression; Humans; Kinetics; Models, Molecular; Mutagenesis, Site-Directed; PII Nitrogen Regulatory Proteins; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Folding; Protein Interaction Domains and Motifs; Proteins; Pyridoxal Phosphate; Recombinant Proteins; Substrate Specificity; Synechococcus; Thermodynamics | 2017 |
Anticonvulsant activity of antagonists and partial agonists for the NMDA receptor-associated glycine site in the kindling model of epilepsy.
Topics: Animals; Anticonvulsants; Cycloserine; Differential Threshold; Epilepsy; Female; Glycine; Kindling, Neurologic; Kynurenic Acid; Pyrrolidinones; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 1994 |
Influence of D-cycloserine on the anticonvulsant activity of phenytoin and carbamazepine against electroconvulsions in mice.
Topics: Animals; Anticonvulsants; Avoidance Learning; Behavior, Animal; Carbamazepine; Cycloserine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Electroshock; Epilepsy; Humans; Male; Memory; Mice; Motor Activity; Phenytoin; Seizures | 1996 |
Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Antimetabolites; Avoidance Learning; Binding, Competitive; Brain Chemistry; Cycloserine; Dizocilpine Maleate; Electroshock; Epilepsy; Excitatory Amino Acid Antagonists; Ligands; Male; Mice; Neurotoxins; Quinolones; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate | 1998 |
Clinical effect of cycloserine on cavity-size, frequency of improvement with remarks on control of side effects.
Topics: Aminosalicylic Acids; Cycloserine; Epilepsy; Humans; Isoniazid; Streptomycin; Tuberculosis | 1970 |
Depression of prahydroxylation of diphenylhydantoin by antituberculosis chemotherapy.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Anticonvulsants; Ataxia; Cycloserine; Drug Incompatibility; Drug Tolerance; Epilepsy; Female; Folic Acid; Humans; Isoniazid; Male; Middle Aged; Nystagmus, Pathologic; Phenytoin; Tuberculosis | 1966 |